Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathieu Kerneis

Showing results (121-130 of 146) with videos related to

Pageof 15
Sort By:
JAMA Cardiology|July 7, 2021
Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor-Associated Myocarditis: A Narrative ReviewLorenz H Lehmann, Jennifer Cautela, Nicolas Palaskas, et al.
Annals of Intensive Care|August 31, 2023
Diagnostic yield, safety and therapeutic consequences of myocardial biopsy in clinically suspected fulminant myocarditis unweanable from mechanical circulatory supportYann Marquet, Guillaume Hékimian, Guillaume Lebreton, et al.
Chest|September 10, 2020
Coronavirus Disease 2019 Acute Myocarditis and Multisystem Inflammatory Syndrome in Adult Intensive and Cardiac Care UnitsGuillaume Hékimian, Mathieu Kerneis, Michel Zeitouni, et al.
American Heart Journal|June 5, 2020
Radial versus femoral artery access for percutaneous coronary artery intervention in patients with acute myocardial infarction and multivessel disease complicated by cardiogenic shock: Subanalysis from the CULPRIT-SHOCK trialPaul Guedeney, Holger Thiele, Mathieu Kerneis, et al.
American Heart Journal|December 24, 2018
The CSL112-2001 trial: Safety and tolerability of multiple doses of CSL112 (apolipoprotein A-I [human]), an intravenous formulation of plasma-derived apolipoprotein A-I, among subjects with moderate renal impairment after acute myocardial infarctionC Michael Gibson, Mathieu Kerneis, Megan K Yee, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 11, 2018
Pre-hospital administration of ticagrelor in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: A sub-analysis of the ATLANTIC trialEnrico Fabris, Arnoud Van't Hof, Christian W Hamm, et al.
JACC. Cardiovascular Interventions|June 6, 2024
Ticagrelor vs Clopidogrel in Clopidogrel-Naive Patients With Chronic Coronary SyndromeStéphane Manzo-Silberman, Paul Guedeney, Guillaume Cayla, et al.
Clinical Cardiology|February 17, 2016
Clinical Outcome of First- vs Second-Generation DES According to DAPT Duration: Results of ARCTIC-GenerationJean-Philippe Collet, Johanne Silvain, Mathieu Kerneis, et al.
Lancet (London, England)|July 20, 2014
Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trialJean-Philippe Collet, Johanne Silvain, Olivier Barthélémy, et al.
European Heart Journal|September 3, 2015
EURObservational Research Programme: the Chronic Ischaemic Cardiovascular Disease Registry: Pilot phase (CICD-PILOT)Michel Komajda, Franz Weidinger, Mathieu Kerneis, et al.
Pageof 15

Showing results (121-130 of 146) with videos related to

Sort By:
Pageof 15
JAMA Cardiology|July 7, 2021
Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor-Associated Myocarditis: A Narrative ReviewLorenz H Lehmann, Jennifer Cautela, Nicolas Palaskas, et al.
Annals of Intensive Care|August 31, 2023
Diagnostic yield, safety and therapeutic consequences of myocardial biopsy in clinically suspected fulminant myocarditis unweanable from mechanical circulatory supportYann Marquet, Guillaume Hékimian, Guillaume Lebreton, et al.
Chest|September 10, 2020
Coronavirus Disease 2019 Acute Myocarditis and Multisystem Inflammatory Syndrome in Adult Intensive and Cardiac Care UnitsGuillaume Hékimian, Mathieu Kerneis, Michel Zeitouni, et al.
American Heart Journal|June 5, 2020
Radial versus femoral artery access for percutaneous coronary artery intervention in patients with acute myocardial infarction and multivessel disease complicated by cardiogenic shock: Subanalysis from the CULPRIT-SHOCK trialPaul Guedeney, Holger Thiele, Mathieu Kerneis, et al.
American Heart Journal|December 24, 2018
The CSL112-2001 trial: Safety and tolerability of multiple doses of CSL112 (apolipoprotein A-I [human]), an intravenous formulation of plasma-derived apolipoprotein A-I, among subjects with moderate renal impairment after acute myocardial infarctionC Michael Gibson, Mathieu Kerneis, Megan K Yee, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 11, 2018
Pre-hospital administration of ticagrelor in diabetic patients with ST-elevation myocardial infarction undergoing primary angioplasty: A sub-analysis of the ATLANTIC trialEnrico Fabris, Arnoud Van't Hof, Christian W Hamm, et al.
JACC. Cardiovascular Interventions|June 6, 2024
Ticagrelor vs Clopidogrel in Clopidogrel-Naive Patients With Chronic Coronary SyndromeStéphane Manzo-Silberman, Paul Guedeney, Guillaume Cayla, et al.
Clinical Cardiology|February 17, 2016
Clinical Outcome of First- vs Second-Generation DES According to DAPT Duration: Results of ARCTIC-GenerationJean-Philippe Collet, Johanne Silvain, Mathieu Kerneis, et al.
Lancet (London, England)|July 20, 2014
Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trialJean-Philippe Collet, Johanne Silvain, Olivier Barthélémy, et al.
European Heart Journal|September 3, 2015
EURObservational Research Programme: the Chronic Ischaemic Cardiovascular Disease Registry: Pilot phase (CICD-PILOT)Michel Komajda, Franz Weidinger, Mathieu Kerneis, et al.
Pageof 15